Clinical Trial Update: Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 long-term safety study of bicifadine for chronic low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Bicifadine (bicifadine)

Snippet

Sponsor: DOV Pharmaceutical, Inc. | Conditions: Chronic Low Back Pain | Phase 3 | Status: COMPLETED